{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:04:31Z","timestamp":1723161871734},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,7]]},"DOI":"10.7759\/cureus.66405","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:42:05Z","timestamp":1723077725000},"source":"Crossref","is-referenced-by-count":0,"title":["Unilateral Vogt-Koyanagi-Harada Disease With Two Distinct Choroidal Neovascular Membranes: A Case Report"],"prefix":"10.7759","author":[{"given":"Raeba","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boopathy","family":"Murugavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/02713680802233968","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"33","author":"Fang W","year":"2008","unstructured":"Fang W, Yang P. Vogt-Koyanagi-Harada syndrome. Curr Eye Res. 2008, 33:517-23. 10.1080\/02713680802233968","journal-title":"Curr Eye Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(01)00937-0","article-title":"Complications and prognostic factors in Vogt-Koyanagi-Harada disease","volume":"131","author":"Read RW","year":"2001","unstructured":"Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, Rao NA. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001, 131:599-606. 10.1016\/s0002-9394(01)00937-0","journal-title":"Am J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-021-00237-3","article-title":"Vogt-Koyanagi-Harada disease is always bilateral: reports of unilateral cases failed to use choroidal investigations showing subclinical involvement of the fellow eye","volume":"11","author":"Papasavvas I","year":"2021","unstructured":"Papasavvas I, Herbort CP Jr. Vogt-Koyanagi-Harada disease is always bilateral: reports of unilateral cases failed to use choroidal investigations showing subclinical involvement of the fellow eye. J Ophthalmic Inflamm Infect. 2021, 11:6. 10.1186\/s12348-021-00237-3","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_262_16","article-title":"Inflammatory choroidal neovascularization in Indian eyes: etiology, clinical features, and outcomes to anti-vascular endothelial growth factor","volume":"65","author":"Roy R","year":"2017","unstructured":"Roy R, Saurabh K, Bansal A, Kumar A, Majumdar AK, Paul SS. Inflammatory choroidal neovascularization in Indian eyes: etiology, clinical features, and outcomes to anti-vascular endothelial growth factor. Indian J Ophthalmol. 2017, 65:295-300. 10.4103\/ijo.IJO_262_16","journal-title":"Indian J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/tjosr.tjosr_67_20","article-title":"A rare case report of peri\u2010papillary choroidal neovascularization in Vogt\u2010Koyanagi\u2010Harada disease","volume":"58","author":"Prakash S","year":"2020","unstructured":"Prakash S, Rathinam SR. A rare case report of peri\u2010papillary choroidal neovascularization in Vogt\u2010Koyanagi\u2010Harada disease. TNOA J Ophthalmic Sci Res. 2020, 58:298-301. 10.4103\/tjosr.tjosr_67_20","journal-title":"TNOA J Ophthalmic Sci Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S34294","article-title":"Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization","volume":"6","author":"Mansour AM","year":"2012","unstructured":"Mansour AM, Mackensen F, Mahendradas P, Khairallah M, Lai TY, Bashshur Z. Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization. Clin Ophthalmol. 2012, 6:1233-7. 10.2147\/OPTH.S34294","journal-title":"Clin Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2016.1236969","article-title":"Adalimumab treatment in patients with Vogt-Koyanagi-Harada disease","volume":"26","author":"Couto C","year":"2018","unstructured":"Couto C, Schlaen A, Frick M, Khoury M, Lopez M, Hurtado E, Goldstein D. Adalimumab treatment in patients with Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2018, 26:485-9. 10.1080\/09273948.2016.1236969","journal-title":"Ocul Immunol Inflamm"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs DA","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS, et al.. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000, 130:492-513. 10.1016\/s0002-9394(00)00659-0","journal-title":"Am J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.08.030","article-title":"Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease","volume":"117","author":"Rao NA","year":"2010","unstructured":"Rao NA, Gupta A, Dustin L, et al.. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010, 117:591-9, 599.e1. 10.1016\/j.ophtha.2009.08.030","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(95)30968-2","article-title":"The natural history of idiopathic subfoveal choroidal neovascularization","volume":"102","author":"Ho AC","year":"1995","unstructured":"Ho AC, Yannuzzi LA, Pisicano K, DeRosa J. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology. 1995, 102:782-9. 10.1016\/s0161-6420(95)30968-2","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9982883","article-title":"Inflammatory choroidal neovascular membranes: clinical profile, treatment effectiveness, and visual prognosis","volume":"2021","author":"Carrola G","year":"2021","unstructured":"Carrola G, Lima-Fontes M, Falc\u00e3o-Reis F, Figueira L, Carneiro \u00c2. Inflammatory choroidal neovascular membranes: clinical profile, treatment effectiveness, and visual prognosis. J Ophthalmol. 2021, 2021:9982883. 10.1155\/2021\/9982883","journal-title":"J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-018-0155-6","article-title":"An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management","volume":"8","author":"Agarwal A","year":"2018","unstructured":"Agarwal A, Invernizzi A, Singh RB, et al.. An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management. J Ophthalmic Inflamm Infect. 2018, 8:13. 10.1186\/s12348-018-0155-6","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181ed8cec","article-title":"Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months","volume":"31","author":"Arevalo JF","year":"2011","unstructured":"Arevalo JF, Adan A, Berrocal MH, et al.. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Retina. 2011, 31:353-63. 10.1097\/IAE.0b013e3181ed8cec","journal-title":"Retina"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the MINERVA study","volume":"38","author":"Lai TY","year":"2018","unstructured":"Lai TY, Staurenghi G, Lanzetta P, et al.. Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the MINERVA study. Retina. 2018, 38:1464-77. 10.1097\/IAE.0000000000001744","journal-title":"Retina"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1687731","article-title":"Outcomes of intravitreal bevacizumab in choroidal neovascularization in Vogt-Koyanagi-Harada disease- a prospective study","volume":"29","author":"Sakata VM","year":"2021","unstructured":"Sakata VM, Morita C, Lavezzo MM, et al.. Outcomes of intravitreal bevacizumab in choroidal neovascularization in Vogt-Koyanagi-Harada disease- a prospective study. Ocul Immunol Inflamm. 2021, 29:572-8. 10.1080\/09273948.2019.1687731","journal-title":"Ocul Immunol Inflamm"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306244","article-title":"Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt-Koyanagi-Harada disease","volume":"99","author":"Hosoda Y","year":"2015","unstructured":"Hosoda Y, Hayashi H, Kuriyama S. Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2015, 99:1211-4. 10.1136\/bjophthalmol-2014-306244","journal-title":"Br J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2623-1","article-title":"Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis","volume":"34","author":"Latronico ME","year":"2015","unstructured":"Latronico ME, Rigante D, Caso F, et al.. Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis. Clin Rheumatol. 2015, 34:1145-8. 10.1007\/s10067-014-2623-1","journal-title":"Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281789-unilateral-vogt-koyanagi-harada-disease-with-two-distinct-choroidal-neovascular-membranes-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:42:10Z","timestamp":1723077730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281789-unilateral-vogt-koyanagi-harada-disease-with-two-distinct-choroidal-neovascular-membranes-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.66405","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,7]]}}}